Virtual Meeting to be held on November 14 hosted by Clear Street.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on AVBP:
- ArriVent Biopharma price target lowered to $31 from $33 at Citi
- ArriVent BioPharma Reports Q3 2025 Financial Results
- ArriVent BioPharma’s Promising Trial Results and Strategic Developments Drive Buy Rating
- ArriVent Biopharma reports Q3 EPS (83c), consensus (78c)
- ArriVent Biopharma price target raised to $47 from $32 at Clear Street